Trial of innovative HIV vaccine using mRNA technology enrolls first participant
The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna. The study evaluates the safety of and immune responses ...
Mar 14, 2022
0
21